ANN ARBOR ? The Southeast Center for Integrated Metabolomics has been awarded a five-year, $9 million grant from the National Institutes of Health. IROA Technologies, formerly NextxGen Metabolomics, is a founding member along with the University of Florida.
With the grant funding, the SECIM is developing an integrated metabolomics service to provide highquality data, user-friendly statistical analysis tools, training and pilot funding to help users get the most out of a metabolomics study, whether it is a basic science metabolomics study or for clinical purposes.
?The IROA protocol represents an important step in the evolution of metabolomics,? said Chris Beecher, Chief Scientific Officer of IROA Technologies. ?The inclusion of IROA as a core platform in the SECIM center is tremendous.?
IROA Technologies develops metabolic profiling tools for the comprehensive analysis of a biological system?s global metabolism with enhanced ability to identify and quantitate compounds, and provide accurate data interpretation.
The CEO of IROA Technologies, Felice de Jong expressed that she was also proud and excited that IROA has joined the SECIM. ?The expertise of the multiple core resources within the university is leveraged and integrated with world-class tools and technology. This Center has every opportunity to revolutionize the way we currently measure metabolites and the world will benefit through the discoveries that will be made at the SECIM. We look forward to advancing the IROA protocol.?
IROA Technologies received a seed round financing last April of $1.5 million, which included the Michigan Pre-Seed Investment Fund and the First Step Fund.
